Skip to content

Lipid profile analysis of rosacea based on serum lipidomics study

Lipid profile analysis of rosacea based on serum lipidomics study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099069
Enrollment
Unknown
Registered
2025-03-18
Start date
2025-01-05
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea

Interventions

Control group:None
Case group:None

Sponsors

Chengdu Science and Technology Bureau ,Sichuan Science and Technology Department
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients in the case group must have been diagnosed with rosacea by different doctors at least twice, and meet the Chinese Guidelines for the Diagnosis and Treatment of Rosacea (2021 Edition), and healthy controls must have no seborrheic dermatitis, acne and other skin diseases, and no facial rash; 2. Agree to sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those who have systematically used antibiotics or antifungal drugs in the last 28 days; 2. Patients with severe internal diseases, HP infections, neurological and mental disorders or behavioral disorders; 3. Facial diseases complicated, such as: acne, psoriasis, systemic lupus erythematosus, seborrheic dermatitis, etc.; 4. Pregnant females; 5. Those who refuse to sign informed consent.

Design outcomes

Primary

MeasureTime frame
Lipid;

Countries

China

Contacts

Public ContactFeng Yanyan

Chengdu Second People's Hospital

drfengyy@163.com+86 139 9916 3793

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026